Migraine Drugs Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
Global Migraine Drugs Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Migraine Drugs Market Global Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2024-2032," the global migraine drugs
  market size reached US 4.2 Billion in 2023.
• Migraine drugs refer to medications that are used
  to reduce the severity of migraines and prevent
  future attacks. A migraine is a severe,
  neurological disease with a debilitating
  headache, characterized by an intense throbbing
  or pulsing in one area of the head.
• It is accompanied by sensitivity to light, sound
  and smell, visual disturbances such as auras, and
  nausea or vomiting. Migraine drugs do not cure
  migraines instead, they treat or relieve these
  symptoms. There are certain blood pressure
  medications, as well as some antidepressants,
  anti-seizure drugs and herbals that are used to
  reduce the frequency of migraines.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/migraine-drugs-market/r
  equestsample

4
Report Description

• Global Migraine Drugs Market Trends
• According to the Migraine Trust, migraine is the
  third most common disease globally, with more
  than 10 of people getting affected by the
  condition worldwide. This represents the primary
  factor that has increased the demand for migraine
  drugs across the globe. Apart from this, the
  rising healthcare expenditure and improving
  reimbursement policies for migraine medications
  are also acting as growth-inducing factors.
• Besides this, healthcare providers have made
  significant advancements in the diagnosis and
  treatment of migraine. A more advanced treatment
  modality with mechanism-based therapies,
  including supraorbital transcutaneous stimulation
  (STS) and transcranial magnetic stimulation, has
  been introduced as a preventive therapy for
  migraine. Additionally, there are many other
  drugs with novel mechanisms of action or new
  therapeutic targets, which are in different
  development stages.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/migraine-drugs-market

5
Report Segmentation

• Breakup by Treatment Type
• Abortive Treatment
• Preventive Treatment
•  
• Breakup by Drug Type
• Triptans
• Ergot Alkaloids
• NSAIDs
• Acetylcholine Inhibitors/ Neurotoxins
• Ditans
• CGRP mAbs
• Others
• Breakup by Route of Administration
• Oral

6
Report Segmentation

• Injectable
• Others
• Breakup by Distribution Channel
• Hospital-Based Pharmacies
• Retail Pharmacies
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Abbott Laboratories
• Allergan Plc (Abbvie Inc.)
• Amgen Inc.
• AstraZeneca Plc
• Bausch Health Companies Inc. (formerly Valeant
  Pharmaceuticals)
• Eisai Co. Ltd.
• Eli Lilly and Company
• Endo International Plc
• GlaxoSmithKline Plc
• Johnson Johnson
• Merck Co.
• Novartis AG
• Pfizer Inc.
• Sanofi SA
• Teva Pharmaceutical Industries Limited.

8
Key Questions Answered in the Report
9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Migraine Drugs
  Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Treatment Type    6.1  
   Abortive Treatment        6.1.1 Market Trends 
        6.1.2 Market Forecast    6.2    Preventive
  Treatment        6.2.1 Market Trends       
  6.2.2 Market Forecast7   Market Breakup by Drug
  Type    7.1    Triptans        7.1.1 Market
  Trends        7.1.2 Market Forecast       

11
Table of Contents

•     7.2    Ergot Alkaloids        7.2.1 Market
  Trends        7.2.2 Market Forecast    7.3  
   NSAIDs        7.3.1 Market Trends        7.3.2
  Market Forecast    7.4    Acetylcholine
  Inhibitors/ Neurotoxins        7.4.1 Market
  Trends        7.4.2 Market Forecast    7.5  
   Ditans        7.5.1 Market Trends        7.5.2
  Market Forecast    7.6    CGRP mAbs       
  7.6.1 Market Trends        7.6.2 Market
  Forecast    7.7    Others        7.7.1 Market
  Trends        7.7.2 Market Forecast8   Market
  Breakup by Route of Administration    8.1  
   Oral        8.1.1 Market Trends        8.1.2
  Market Forecast    8.2    Injectable       
  8.2.1 Market Trends        8.2.2 Market
  Forecast    8.3    Others        8.3.1 Market
  Trends        8.3.2 Market Forecast
• For more information, visit https//www.imarcgrou
  p.com/migraine-drugs-market/toc

12
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

13
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com